Duane H Hamilton

5PUBLICATIONS

14CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 01, 2026

PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regression.

|May 19, 2025

Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer.

Maria Gracia-Hernandez, Maria Del Mar Maldonado, Jeffrey Schlom

|May 13, 2025

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control.

Maria Del Mar Maldonado, Maria Gracia-Hernandez, Loc Huu Le

|Jul 08, 2024

Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines.

Jeffrey Schlom, Renee N Donahue, Claudia Palena

|Jul 28, 2023

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.

Maria Del Mar Maldonado, Jeffrey Schlom, Duane H Hamilton

Pageof 1

Frequent Collaborators

4 joint publications

Jeffrey Schlom

3 joint publications

Maria Del Mar Maldonado

James L Gulley

Renee N Donahue

Claudia Palena

James W Hodge

Maria Gracia-Hernandez

1 joint publications

Sofia R Gameiro

1 joint publications

Loc Huu Le

1 joint publications

Masafumi Iida

Frequent Collaborators

4 joint publications

Jeffrey Schlom

3 joint publications

Maria Del Mar Maldonado

3 joint publications

James L Gulley

2 joint publications

Renee N Donahue